Loading clinical trials...
Loading clinical trials...
Hepatic steatosis and insulin resistance are associated with severity of fibrosis in non-alcoholic fatty liver disease (NAFLD) and chronic hepatitis C. However, clinical significance of steatosis and ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Seoul National University Boramae Hospital
NCT02417740 · Cystic Fibrosis, Immunologic Deficiency Syndrome, and more
NCT07417553 · Chronic Hepatitis B-related Liver Fibrosis
NCT05623150 · Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis, and more
NCT07265544 · Liver Neoplasm, HBV Infection, and more
NCT07518784 · MASLD, MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease), and more
Seoul Metropolitan Government Seoul National University
Seoul
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions